1 citations
,
January 2013 This study observed that inducible deletion of the Ugcg gene in mouse epidermis led to a significant reduction in GlcCers and epidermal POS-Cers, causing impaired skin barrier function and delayed wound healing.
1 citations
,
January 2012 in “Jounal of The Korean Society of cosmetology” Tremella fuciformis Berk helps protect hair from stress-related damage.
1 citations
,
August 2000 in “Expert Opinion on Therapeutic Patents” This article reviews the therapeutic use of carnitine derivatives for re-establishing mitochondrial functionality in aging and reports no new clinical results.
June 2026 in “Wiener klinische Wochenschrift” This review highlights advancements in the understanding and treatment of alopecia areata, noting that the approval of oral Janus kinase inhibitors like baricitinib and ritlecitinib marks a significant development in managing severe cases of this autoimmune condition.
May 2026 in “International Journal of Pharmaceutical Quality Assurance” This study reported that among 95 women with polycystic ovarian syndrome at a tertiary care hospital in India, menstrual irregularities were the most common issue, affecting 86.3% of participants, with many also experiencing hyperandrogenic symptoms, obesity, and infertility.
May 2026 in “Malahayati Nursing Journal” In this study, a single alopecia patient receiving acupuncture therapy for six weeks displayed gradual improvements, including reduced hair loss, better scalp condition, and enhanced comfort and sleep, suggesting acupuncture may be a safe complementary treatment option for alopecia management.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common, with different types affecting people due to genetics, stress, or autoimmune issues.
April 2026 in “International Journal of Homoeopathic Sciences” This case report highlights the role of mental symptoms in tailoring homoeopathic treatment for a 24-year-old male with alopecia barbae, a localized non-scarring hair loss condition affecting the beard, emphasizing the psychological component in its management.
April 2026 in “Expert Opinion on Biological Therapy” This review discusses prurigo nodularis and reports no new results, emphasizing the need for further research into its pathophysiology and treatment options.
March 2026 in “Tạp chí Da liễu học Việt Nam” In this review, researchers conclude that immune imbalance between regulatory and cytotoxic T cells, along with activation of IFN-γ–MHC and IL-15–NK pathways, disrupts hair follicle immune privilege, suggesting pivotal mechanisms in alopecia areata development and potential targets for immunotherapeutic interventions.
March 2026 in “JMIR Dermatology” This article highlights the rising interest in Janus kinase inhibitors for alopecia areata, especially following the FDA approval of baricitinib, underscoring the need for better patient education and physician guidance in selecting appropriate treatments for hair loss.
February 2026 in “International Journal For Multidisciplinary Research” In this randomized open-label clinical trial, researchers found that regular application of Bhringarajadi Taila significantly improved hair fall and scalp condition in patients with Khalitya (alopecia), with 62.5% of participants experiencing moderate to remarkable improvement after 30 days of treatment.
January 2026 in “International Research Journal of Modernization in Engineering Technology and Science” This review outlines the existing understanding of alopecia areata, detailing its autoimmune nature, clinical presentation, histology, and management strategies, with corticosteroids highlighted as the most popular treatment option.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers explored the formulation and effectiveness of herbal shampoos, finding that these products offer a gentler hair care alternative that promotes hair health and addresses scalp issues, while also encouraging sustainable beauty practices and consumer awareness.
January 2026 in “International Journal of Research and Innovation in Applied Science” This article discusses the similarities between alopecia areata and Indralupta in Ayurveda and reports no new clinical results, highlighting traditional and modern management approaches for the condition.
December 2025 in “Journal of the Korean Society of Cosmetology” This study observed that among adults in their 20s and 30s, deteriorating scalp and hair health increased hair loss stress, which in turn prompted more proactive scalp care behaviors, with hair condition being a stronger motivator than scalp condition.
This article discusses the management of pediatric alopecia areata in children aged 6 to 11, emphasizing the need for psychosocial support and limited medical treatments, as no systemic therapies are FDA-approved for this age group, despite the significant psychosocial burden.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This case report documents a successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda could help restore balance and promote hair regrowth in this autoimmune condition.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This case report describes the successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda may aid in rebalancing the body and promoting hair regrowth in autoimmune conditions.
September 2025 in “Clinics and Practice” This study found that six-month supplementation with fish-derived collagen peptides, calcium, and vitamin D3 improved skin hydration and elasticity and reduced hair loss in menopausal women, with collagen playing a dominant role in enhancing skin elasticity.
September 2025 in “medRxiv (Cold Spring Harbor Laboratory)” This study found that applying a topical scalp essence with Centella asiatica extracellular vesicles and growth factors significantly improved scalp health and hair growth compared to a placebo after 56 days.
September 2025 in “PubMed” This source describes a case where a patient with Crohn's disease experienced remission of alopecia universalis after a colectomy, suggesting that addressing the intestinal inflammatory source might influence autoimmune manifestations like hair loss.
In this review, researchers analyzed literature on trichotillomania and found advances in understanding its neurobiology—highlighting dysregulated reward circuits and genetics—and treatments, with behavioral therapy and innovative pharmacological approaches improving outcomes where traditional SSRIs do not.
In this literature review, researchers highlighted that trichotillomania involves dysregulated reward circuits, abnormal sensory processing, and potential genetic factors, advancing both therapeutic strategies and understanding of the condition, but stigma and provider training gaps persist in effective care provision.
In this case study, individualized homeopathic treatment resulted in complete hair regrowth with no recurrence in a patient with Alopecia Areata, highlighting the potential of homeopathy for managing autoimmune hair loss effectively.
This study examined molecular predictors of ritlecitinib efficacy in treating alopecia areata, highlighting the role of JAK3-dependent inflammation and follicular integrity as important factors in understanding disease mechanisms and potential therapeutic effectiveness.
August 2025 in “International Journal of Research Publication and Reviews” This study suggests that stress intensity is highly correlated with hairfall severity, highlighting the potential of an inexpensive and accessible machine learning approach for forecasting and prevention.
This case report details a 47-year-old female with atopic dermatitis who developed alopecia areata after six months on dupilumab therapy; treatment discontinuation and other interventions led to complete hair regrowth, suggesting dupilumab may trigger alopecia areata in patients with atopic or autoimmune predispositions.
July 2025 in “International Journal of Ayurveda and Pharma Research” This study reported that a month-long treatment using the Ayurvedic methods of leech therapy, herbal paste application, and rejuvenative medications resulted in visible improvement in scalp condition and hair density for a 32-year-old female with androgenetic alopecia.
July 2025 in “International Journal of Pharmaceutical Sciences Review and Research” This case report documented a 20-year-old male with alopecia areata who experienced slight hair regrowth following treatment with cyclosporine and methylprednisolone, highlighting the importance of individualized treatment plans and consideration of medication side effects.